[go: up one dir, main page]

IL111660A - Oligonucleoside compounds for effecting rnaseh-mediated cleavage of a target ribonucleic acid sequence and a pharmaceutical composition containing them - Google Patents

Oligonucleoside compounds for effecting rnaseh-mediated cleavage of a target ribonucleic acid sequence and a pharmaceutical composition containing them

Info

Publication number
IL111660A
IL111660A IL11166094A IL11166094A IL111660A IL 111660 A IL111660 A IL 111660A IL 11166094 A IL11166094 A IL 11166094A IL 11166094 A IL11166094 A IL 11166094A IL 111660 A IL111660 A IL 111660A
Authority
IL
Israel
Prior art keywords
rnaseh
effecting
acid sequence
pharmaceutical composition
composition containing
Prior art date
Application number
IL11166094A
Other versions
IL111660A0 (en
Original Assignee
Genta Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genta Inc filed Critical Genta Inc
Priority to IL12865894A priority Critical patent/IL128658A/en
Publication of IL111660A0 publication Critical patent/IL111660A0/en
Priority to IL12865899A priority patent/IL128658A0/en
Publication of IL111660A publication Critical patent/IL111660A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL11166094A 1993-11-16 1994-11-16 Oligonucleoside compounds for effecting rnaseh-mediated cleavage of a target ribonucleic acid sequence and a pharmaceutical composition containing them IL111660A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IL12865894A IL128658A (en) 1993-11-16 1994-11-16 Oligonucleoside compounds for effecting rnaseh mediated cleavage of a target ribonucleic acid sequence and a pharmaceutical composition containing them
IL12865899A IL128658A0 (en) 1993-11-16 1999-02-23 Oligonucleoside compounds for effecting RNaseH mediated cleavage of a target ribonucleic acid sequence

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US15401393A 1993-11-16 1993-11-16
US15401493A 1993-11-16 1993-11-16
US23377894A 1994-04-26 1994-04-26
US23817794A 1994-05-04 1994-05-04

Publications (2)

Publication Number Publication Date
IL111660A0 IL111660A0 (en) 1995-01-24
IL111660A true IL111660A (en) 2005-05-17

Family

ID=27496113

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11166094A IL111660A (en) 1993-11-16 1994-11-16 Oligonucleoside compounds for effecting rnaseh-mediated cleavage of a target ribonucleic acid sequence and a pharmaceutical composition containing them

Country Status (8)

Country Link
EP (1) EP0743859A4 (en)
JP (1) JPH09506248A (en)
KR (1) KR960705589A (en)
AU (1) AU689182B2 (en)
CA (1) CA2176259A1 (en)
IL (1) IL111660A (en)
NZ (1) NZ277617A (en)
WO (1) WO1995013834A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996031600A1 (en) * 1995-04-03 1996-10-10 Hybridon, Inc. Method of modulating gene expression without depleting complement
US6509149B2 (en) * 1995-06-06 2003-01-21 Hybridon, Inc. HPV-specific oligonucleotides
US5898031A (en) * 1996-06-06 1999-04-27 Isis Pharmaceuticals, Inc. Oligoribonucleotides for cleaving RNA
WO1999050409A1 (en) * 1998-04-01 1999-10-07 Hybridon, Inc. Mixed-backbone oligonucleotides containing pops blocks to obtain reduced phosphorothioate content
US6277967B1 (en) 1998-07-14 2001-08-21 Isis Pharmaceuticals, Inc. Carbohydrate or 2′-modified oligonucleotides having alternating internucleoside linkages
EP2361981B2 (en) 2000-03-30 2019-01-23 The Whitehead Institute for Biomedical Research RNA sequence-specific mediators of RNA interference
KR20080023768A (en) 2000-03-30 2008-03-14 화이트헤드 인스티튜트 포 바이오메디칼 리서치 RNA sequence specific mediator of RNA interference
KR100909681B1 (en) 2000-12-01 2009-07-29 막스-플랑크-게젤샤프트 츄어 푀르더룽 데어 비쎈샤프텐 에.파우. Small RNA molecules that mediate JR interference
US7452987B2 (en) * 2002-08-05 2008-11-18 Silence Therapeutics Aktiengesellschaft (Ag) Interfering RNA molecules
HUE032289T2 (en) * 2002-08-05 2017-09-28 Silence Therapeutics Gmbh Futher novel forms of interfering RNA molecules
US9827263B2 (en) 2002-11-05 2017-11-28 Ionis Pharmaceuticals, Inc. 2′-methoxy substituted oligomeric compounds and compositions for use in gene modulations
US9150605B2 (en) 2002-11-05 2015-10-06 Isis Pharmaceuticals, Inc. Compositions comprising alternating 2′-modified nucleosides for use in gene modulation
US9150606B2 (en) 2002-11-05 2015-10-06 Isis Pharmaceuticals, Inc. Compositions comprising alternating 2'-modified nucleosides for use in gene modulation
EP3205725B1 (en) * 2011-08-11 2019-03-27 Ionis Pharmaceuticals, Inc. Selective antisense compounds and uses thereof
WO2018051762A1 (en) * 2016-09-14 2018-03-22 レナセラピューティクス株式会社 Antisense oligonucleotide with reduced side effects
KR20220070227A (en) * 2019-09-19 2022-05-30 수디르 아그라왈 Compounds and methods available for modulating gene splicing

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212295A (en) * 1990-01-11 1993-05-18 Isis Pharmaceuticals Monomers for preparation of oligonucleotides having chiral phosphorus linkages
US5149797A (en) * 1990-02-15 1992-09-22 The Worcester Foundation For Experimental Biology Method of site-specific alteration of rna and production of encoded polypeptides
KR940703846A (en) * 1991-12-24 1994-12-12 비. 린네 파샬 GAPED 2 'MODIFED OLIGONUCLEOTIDES

Also Published As

Publication number Publication date
JPH09506248A (en) 1997-06-24
AU1291695A (en) 1995-06-06
CA2176259A1 (en) 1995-05-26
NZ277617A (en) 1998-01-26
WO1995013834A1 (en) 1995-05-26
EP0743859A1 (en) 1996-11-27
IL111660A0 (en) 1995-01-24
KR960705589A (en) 1996-11-08
EP0743859A4 (en) 1998-10-21
AU689182B2 (en) 1998-03-26

Similar Documents

Publication Publication Date Title
IL111660A (en) Oligonucleoside compounds for effecting rnaseh-mediated cleavage of a target ribonucleic acid sequence and a pharmaceutical composition containing them
AU3455297A (en) Pharmaceutical composition containing acid addition salt of basic drug
ZA937502B (en) Carboxylic acid derivatives pharmaceutical compositions containing these compounds and processes for preparing them
ZA939230B (en) Carboxylic acid derivatives pharmaceutical compositions containing these compounds and processes for preparing them
IL75586A0 (en) Pharmaceutical compositions containing indole-2-alkanoic acids and derivatives thereof,and certain such novel compounds
HUT71106A (en) Propenoic acid derivatives, pharmaceutical compositions containing them and process for their preparation
ZA934090B (en) Biphenyl derivatives pharmaceutical compositions containing these compounds and processes for preparing them
HU200177B (en) Process for producing thiazolidinecarboxylic acids and pharmaceutical compositions comprising such compounds
IL115072A (en) Pharmaceutical compositions containing substituted 4-phenyl-6-amino-nicotinic acid derivatives their preparation some such new compounds and process for their preparation
AU5706486A (en) Pharmaceutical compositions containing pyridinone compounds
IL110157A (en) (1-Heteroazolyl-1-heterocyclyl) alkane derivatives a process for their preparation and pharmaceutical compositions containing them
HUT72319A (en) Epoxy-succinic acid derivatives, pharmaceutical compositions containing them and process for their preparation
IL80820A0 (en) Imidazopyridazinealkenoic acid amides,processes and intermediate compounds for their preparation and pharmaceutical compositions containing them
AU6217186A (en) Pharmaceutical composition of desferrioxamine b or desferriferrithiocine for malaria treatment
ZA966154B (en) Aminophenylphosphonic acid compounds process for preparing them and pharmaceutical compositions containing them
AU610175B2 (en) Pharmaceutical composition comprising a compound containing sulfhydryl group(s) for the treatment of otitis
ZA933638B (en) Heterocyclic compounds a process for the preparation thereof and pharmaceutical compositions containing them
ZA98440B (en) Compounds of boronic acids a process for their preparation and pharmaceutical compositions containing them
IL108920A0 (en) Acyloxyhexanoic acid derivatives and pharmaceutical compositions containing them
AU4959497A (en) Pharmaceutical composition containing bismuth-polyacrylic acid compounds
IL128658A (en) Oligonucleoside compounds for effecting rnaseh mediated cleavage of a target ribonucleic acid sequence and a pharmaceutical composition containing them
AU6190594A (en) New substituted benzodioxins, a process for their preparation and pharmaceutical compositions containing them
HU9400325D0 (en) Process for producing amino-ascorbic acid derivatives and pharmaceutical compositions containing them
ZA94368B (en) Amino acid derivatives pharmaceutical compositions containing these compound and processes for their preparation
EP0564775A3 (en) Process for pharmaceutical grade high purity iodeoxycholic acid preparation

Legal Events

Date Code Title Description
MM9K Patent not in force due to non-payment of renewal fees